Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis

Gastroenterology

Volumn 127, Issue 2, 2004, Pages 493-501

  Selmi, Carlo ^a,b   Ross, Susan R ^c   Ansari, Aftab A ^d   Invernizzi, Pietro ^b   Podda, Mauro ^b   Coppel, Ross L ^e   Gershwin, M Eric ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Paolo Medical School   (Italy)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AMA; antimitochondrial antibodies; BEC; biliary epithelial cell; hTfR1; human transferrin receptor 1; MMTV; mouse mammary tumor virus; PBC; PBL; PCR; PDC E2; peripheral blood lymphocyte; polymerase chain reaction; primary biliary cirrhosis

Indexed keywords

GLYCOPROTEIN; POLYCLONAL ANTIBODY; PROTEIN P27; PROTEIN SUBUNIT; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MOUSE MAMMARY TUMOR ONCOVIRUS; PERIPHERAL LYMPHOCYTE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SERUM; STAINING; TUMOR; VIRION; VIRUS GENOME; VIRUS STRAIN; WESTERN BLOTTING;

EID: 4143106857     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.05.033     Document Type: Article

References (52)

1. Kaplan M.M. Primary biliary cirrhosis. N Engl J Med. 335:1996;1570-1580
2. Van de Water J., Ishibashi H., Coppel R.L., Gershwin M.E. Molecular mimicry and primary biliary cirrhosis premises not promises. Hepatology. 33:2001;771-775
3. Palmer J.M., Kirby J.A., Jones D.E. The immunology of primary biliary cirrhosis the end of the beginning? Clin Exp Immunol. 129:2002;191-197
4. Tsuji K., Watanabe Y., Van De Water J., Nakanishi T., Kajiyama G., Parikh-Patel A., Coppel R., Gershwin M.E. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun. 13:1999;171-178
5. Agarwal K., Jones D.E., Watt F.E., Burt A.D., Floreani A., Bassendine M.F. Familial primary biliary cirrhosis and autoimmune cholangitis. Dig Liver Dis. 34:2002;50-52
6. Parikh-Patel A., Gold E., Mackay I.R., Gershwin M.E. The geoepidemiology of primary biliary cirrhosis contrasts and comparisons with the spectrum of autoimmune diseases. Clin Immunol. 91:1999;206-218
7. Abu-Mouch S., Selmi C., Benson G.D., Kenny T.P., Invernizzi P., Zuin M., Podda M., Rossaro L., Gershwin M.E. Geographic clusters of primary biliary cirrhosis. Clin Dev Immunol. 10:2003;127-131
8. Selmi C., Mayo M.J., Bach N., Ishibashi H., Invernizzi P., Gish R.G., Gordon S.C., Wright H.I., Zweiban B., Podda M., Gershwin M.E. Primary biliary cirrhosis in monozygotic and dizygotic twins genetics, epigenetics, and environment. Gastroenterology. 127:2004;485-492
9. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., Selmi C., Watnik M., Gershwin M.E., Podda M. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet. 363:2004;533-535
10. Long S.A., Van de Water J., Gershwin M.E. Antimitochondrial antibodies in primary biliary cirrhosis the role of xenobiotics. Autoimmun Rev. 1:2002;37-42
11. Leung P.S., Quan C., Park O., Van de Water J., Kurth M.J., Nantz M.H., Ansari A.A., Coppel R.L., Lam K.S., Gershwin M.E. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol. 170:2003;. 5326-5232
12. Bogdanos D.P., Choudhuri K., Vergani D. Molecular mimicry and autoimmune liver disease virtuous intentions, malign consequences. Liver. 21:2001;225-232
13. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., Leung P.S., Kenny T.P., Van De Water J., Nantz M.H., Kurth M.J., Gershwin M.E. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 38:2003;1250-1257
14. Gershwin M.E., Ansari A.A., Mackay I.R., Nakanuma Y., Nishio A., Rowley M.J., Coppel R.L. Primary biliary cirrhosis an orchestrated immune response against epithelial cells. Immunol Rev. 174:2000;210-225
15. Mason A.L., Xu L., Guo L., Munoz S., Jaspan J.B., Bryer-Ash M., Cao Y., Sander D.M., Shoenfeld Y., Ahmed A., Van de Water J., Gershwin M.E., Garry R.F. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet. 351:1998;1620-1624
16. Xu L., Shen Z., Guo L., Fodera B., Keogh A., Joplin R., O'Donnell B., Aitken J., Carman W., Neuberger J., Mason A. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A. 100:2003;8454-8459
17. Xu L., Sakalian M., Shen Z., Loss G., Neuberger J., Mason A. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology. 39:2004;151-156
18. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277
19. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythe-matosus. Arthritis Rheum. 40:1997;1725
20. Vitali C., Bombardieri S., Moutsopoulos H.M., Balestrieri G., Benci-velli W., Bernstein R.M., Bjerrum K.B., Braga S., Coll J., de Vita S., et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 36:1993;340-347
21. Ludwig J., Dickson E.R., McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 379:1978;103-112
22. Miyakawa H., Tanaka A., Kikuchi K., Matsushita M., Kitazawa E., Kawaguchi N., Fujikawa H., Gershwin M.E. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology. 34:2001;243-248
23. Le Bon A., Wache A.C., Papiernik M. In vivo elimination of viral superantigen-activated CD4+ T cells apoptosis occurs at a distance from the activation site. Int Immunol. 11:1999;373-382
24. Migliaccio C., Nishio A., Van de Water J., Ansari A.A., Leung P.S., Nakanuma Y., Coppel R.L., Gershwin M.E. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol. 161:1998;5157-5163
25. Sasaki M., Ansari A., Pumford N., van de Water J., Leung P.S., Humphries K.M., Szweda L.I., Nakanuma Y., Roche T.E., Coppel R.L., Bach J.F., Gershwin M.E. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis searching for a mimic. J Autoimmun. 15:2000;51-60
26. Wang Y., Holland J.F., Bleiweiss I.J., Melana S., Liu X., Pelisson I., Cantarella A., Stellrecht K., Mani S., Pogo B.G. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res. 55:1995;5173-5179
27. Majors J.E., Varmus H.E. Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene. J Virol. 47:1983;495-504
28. Golovkina T.V., Dudley J.P., Jaffe A.B., Ross S.R. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc Natl Acad Sci U S A. 92:1995;4828-4832
29. Badenhoop K., Donner H., Neumann J., Herwig J., Kurth R., Usadel K.H., Tonjes R.R. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes. 48:1999;215-218
30. Golovkina T.V., Chervonsky A., Prescott J.A., Janeway C.A. Jr, Ross S.R. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J Exp Med. 179:1994;439-446
31. Golovkina T.V., Piazzon I., Nepomnaschy I., Buggiano V., de Olano Vela M., Ross S.R. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J Virol. 71:1997;3895-3903
32. Yoshimoto T., Nagase H., Nakano H., Matsuzawa A., Nariuchi H. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice. Eur J Immunol. 24:1994;1612-1619
33. Dubel L., Tanaka A., Leung P.S., Van de Water J., Coppel R., Roche T., Johanet C., Motokawa Y., Ansari A., Gershwin M.E. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology. 29:1999;1013-1018
34. Sadamoto T., Joplin R., Keogh A., Mason A., Carman W., Neuberger J. Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet. 352:1998;1595-1596
35. Czarneski J., Rassa J.C., Ross S.R. Mouse mammary tumor virus and the immune system. Immunol Res. 27:2003;469-480
36. Ross S.R. Using genetics to probe host-virus interactions; the mouse mammary tumor virus model. Microbes Infect. 2:2000;1215-1223
37. Mant C., Gillett C., D'Arrigo C., Cason J. Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies. Virology. 318:2004;393-404
38. Mason A., Farr G., Hubscher S., Neuberger J. Pilot study of single and combination anti-retroviral therapy in patients with primary biliary cirrhosis. Hepatology. 38:2003;102A. (abstr)
39. Friis-Moller N., Sabin C.A., Weber R., d'Arminio Monforte A., El-Sadr W.M., Reiss P., Thiebaut R., Morfeldt L., De Wit S., Pradier C., Calvo G., Law M.G., Kirk O., Phillips A.N., Lundgren J.D. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 349:2003;1993-2003
40. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869
41. Nakanuma Y., Kono N., Ohta G., Kato Y., Kobayashi K. Ultrastructural changes of bile duct epithelium in primary biliary cirrhosis in relation to progression of bile duct loss. Virchows Arch A Pathol Anat Histopathol. 398:1982;149-161
42. Nakanuma Y., Ohta G., Kono N., Kobayashi K., Kato Y. Electron microscopic observation of destruction of biliary epithelium in primary biliary cirrhosis. Liver. 3:1983;238-248
43. Fukushima N., Nalbandian G., Van De Water J., White K., Ansari A.A., Leung P., Kenny T., Kamita S.G., Hammock B.D., Coppel R.L., Stevenson F., Ishibashi H., Gershwin M.E. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC. Hepatology. 36:2002;1383-1392
44. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 108:2001;223-232
45. Holder W.D. Jr, Wells S.A. Jr. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma a possible serological detection method for breast carcinoma. Cancer Res. 43:1983;239-244
46. Dion A.S., Girardi A.J., Williams C.C., Pomenti A.A., Redfield E.S. Responses of serum from breast cancer patients to murine mammary tumor virus fact or artifact? J Natl Cancer Inst. 79:1987;207-211
47. Ross S.R., Schofield J.J., Farr C.J., Bucan M. Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus. Proc Natl Acad Sci U S A. 99:2002;12386-12390
48. Zhang Y., Rassa J.C., deObaldia M.E., Albritton L.M., Ross S.R. Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein. J Virol. 77:2003;10468-10478
49. Adelman M.K., Marchalonis J.J. Endogenous retroviruses in systemic lupus erythematosus candidate lupus viruses. Clin Immunol. 102:2002;107-116
50. Yamano S., Renard J.N., Mizuno F., Narita Y., Uchida Y., Higashiyama H., Sakurai H., Saito I. Retrovirus in salivary glands from patients with Sjögren's syndrome. J Clin Pathol. 50:1997;223-230
51. Lindenborn-Fotinos J., Baum H., Berg P.A. Mitochondrial antibodies in primary biliary cirrhosis species and nonspecies specific determinants of M2 antigen. Hepatology. 5:1985;763-769
52. Carr A., Cooper D.A. Adverse effects of antiretroviral therapy. Lancet. 356:2000;1423-1430